Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation

Neurobiology of Disease

Volumn 42, Issue 3, 2011, Pages 211-220

  Sta, M ^a   Sylva Steenland, R M R ^a   Casula, M ^a   de Jong, J M B V ^a   Troost, D ^a   Aronica, E ^a   Baas, F ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Amyotrophic Lateral Sclerosis; Complement system; Neuroinflammation

Indexed keywords

CD209 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; MESSENGER RNA;

ADAPTIVE IMMUNITY; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; MALE; MICROGLIA; MOTOR CORTEX; MOTOR NEURON DISEASE; PRIORITY JOURNAL; SPINAL CORD;

ADAPTIVE IMMUNITY; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; MICROGLIA; MIDDLE AGED; MOTOR NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 79952618146     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.01.002     Document Type: Article

References (39)

1. Alexander J.J., Anderson A.J., Barnum S.R., Stevens B., Tenner A.J. The complement cascade: Yin-Yang in neuro-protection and -degeneration. J. Neurochem. 2008, 107:1169-1187.
2. Appel S.H., Beers D.R., Henkel J.S. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?. Trends Immunol. 2010, 1:7-17.
3. Aronica E., Catania M.V., Geurts J., Yankaya B., Troost D. Immunohistochemical localization of group I and II metabotrophic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 2001, 105:509-520.
4. Bhakdi S., Branum-Jensen J. Complement lysis: a hole is a hole. Immunol. Today 1991, 12:318-320.
5. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
6. Budde B.S., Namavar Y., Barth P.G., Poll-The B.T., Nürnberg G., et al. tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat. Genet. 2008, 40:1113-1118.
7. Chou S.M. Pathology of the motor system. Motor Neuron Disease 1995, 53-95. Springer-Verlag, London. P.N. Leigh, M. Swash (Eds.).
8. Chiu I.M., Chen A., Zheng Y., Kosaras B., Tsiftsoglou S.A., et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. USA 2008, 105(40):17913-17918.
9. Chiu I.M., Phatnani H., Kuligowski M., Tapia J.C., Carrasco M.A., et al. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenetic mice. Proc. Natl Acad. Sci. 2009, 106:20960-20965.
10. Färber K., Cheung G., Mitchell D., Wallis R., Weihe E., et al. C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J. Neurosci. Res. 2008, 87:644-652.
11. Ferraiuolo L., Heath P.R., Holden H., Kasher P., Kirby J., Shaw P.J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. 2007, 27(34):9201-9219.
12. Frank M.M., Fries LF L.F. The role of complement in inflammation and phagocytosis. Immunol. Today 1991, 12:322-326.
13. McGeer P.L., McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2006, 26:459-470.
14. Goldknopf I.L., Sheta E.A., Bryson J., Folsom B., Wilson C., et al. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem. Biophys. Res. Commun. 2006, 342:1034-1039.
15. Harter PN, Bunz K, Dietz K, Hoffmann K, Meyerman R, Mittelbronn M. Spatio-temporal DCC and netrin-1 expression in human fetal brain development. Neuropathol. Appl. Neurobiol. "Accepted article" 2010. doi:10.1011\j.1365-2290.2010.01100.x.
16. Henkel J.S., Engelhardt J.I., Siklós L., Simpson E.P., Kim S.H., Pan T., et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 2004, 55:221-235.
17. Humayun S., Gohar M., Volkening K., Moisse K., Leystra-Lantz C., et al. The complement factor C5a receptor is upregulated in NFL-/- mouse motor neurons. J. Neuroimmunol. 2009, 210:52-62.
18. de Jonge R.R., van Schaik I.N., Vreijling J.P., Troost D., Baas F. Expression of complement components in the peripheral nervous system. Hum. Mol. Genet. 2004, 13:295-302.
19. Karlen Y., McNair A., Persequers S., Mazza C., Mermod N. Statistical significance of quantitative PCR. BMC Bioinform. 2007, 8:131.
20. Kawamata T., Akiyama H., Yamada T., McGreer P.L. Immunological reactions in amyotrophic lateral sclerosis. AJP 1992, 140:691-707.
21. Lertmemongkolchai G., Cai G., Hunter C.A., Bancroft G.J. Bystander activation of CD8 T cells contributes to rapid production of IFN-γ in response to bacterial pathogens. J. Immunol. 2001, 166:1097-1105.
22. Liu S., Wu J., Zhang T., Qian B., Wu P., et al. Complement C1q chemoattracts human dendritic cells and enhances migration of mature dendritic cells to CCL19 via activation of AKT and PAK pathways. Mol. Immunol. 2008, 46:242-249.
23. Lobsiger C.S., Boillée S., Cleveland D.W. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. PNAS 2007, 104:7319-7326.
24. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 2000, 14:129-135.
25. Matsukawa A., Hogaboam C.M., Lukacs N.W., Kunkel S.L. Chemokines and innate immunity. Rev. Immunogenet. 2000, 2:339-358.
26. Moisse K., Strong M.J. Innate immunity in amytrophic lateral sclerosis. Biochim. Biophys. Acta 2006, 1762:1083-1093.
27. Padilla-Docal B, Dorta-Contreras AJ, Bu-Coifiu-Fanego R Rodriquez-Rey A. CSF/serum quotient graphs for the evaluation of intrathecal C4 synthesis. Cerebrospinal Fluid Res. Published online july (2009). doi:10.1186/1743-8454-6-8.
28. Rahemtulla A., Fung-Leung W.P., Schilham M.W., Kundig T.M., Sambhara S.R., et al. Normal development and function of CD8+ cells, but markedly decreased helper activity in mice lacking CD4. Nature 1991, 353:180-184.
29. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reactin (PCR) data. Neurosci. Lett. 2003, 339:62-66.
30. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
31. Schraufslatter I.U., Trieu K., Sikora L., Sriramarao P., DiScipio R. Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J. Immunol. 2002, 169:2102-2110.
32. Sun J.C., Bevan M.J. Defective CD8 T-cell memory following acute infection without CD4 T-cell help. Science 2003, 300:339-349.
33. Tomlinson S. Complement defense mechanisms. Curr. Opin. Immunol. 1993, 5:83-89.
34. Tsuboi Y., Yamada T. Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 1994, 57:859-861.
35. Weydt P., Weiss M.D., Möller T., Carter G.T. Neuro-inflammation as a therapeutic target amyotrophic lateral sclerosis. Curr. Opin. Investig. Drugs 2002, 12:1720-1724.
36. Woodruff T.M., Costantini K.J., Crane J.W., Atkin J.D., Monk P.N., et al. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J. Immunol. 2008, 181:8727-8734.
37. Woodruff T.M., Costatini K.J., Taylor S.M., Noakes P.G. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors. Adv. Exp. Med. Biol. 2008, 632:143-158.
38. Yoshie O. Role of chemokines in trafficking of lymphocytes and dendritic cells. Int. J. Hematol. 2000, 72:399-407.
39. Zipp F., Aktas O. Brain as a target of inflammation, common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 2006, 29:518-527.